CX3CL1 and breast carcinoma: Indeed, high expression of the CX3CL1 molecule by tumor cells was found to correlate with a good prognosis and with increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma (31).